Back to search

Harokopio University

Η επίδραση του μεσογειακού τρόπου ζωής σε κλινικά και βιοχημικά χαρακτηριστικά ασθενών με αποφρακτική άπνοια ύπνου

Abstract

dc:description

Introduction and aim: Obstructive sleep apnea (OSA) is nowadays recognized as a major public health issue and its efficient management is under intense research. The aim of the present study was to explore whether the addition of a weight-loss Mediterranean diet (MD)/lifestyle (ML) intervention to OSA standard care, i.e. prescription of continuous positive airway pressure (CPAP), has an incremental effect on improving: (1) OSA severity and symptomatology, (2) patients’ cardiometabolic profile, and (3) markers of inflammation and oxidative stress, over the effect of standard care alone. Materials and methods: This was a randomized, parallel, controlled, single-blind clinical trial. Eligible candidates were adult, overweight, otherwise healthy patients with moderate-to-severe OSA [apnea-hypopnea index (AHI) ≥15 events/h], diagnosed through an overnight attended in-hospital polysomnography. Participants were blindly randomized to a standard care group (SCG), a MD group (MDG) or a ML group (MLG). All three study groups received standard care for OSA management, i.e. were prescribed with CPAP therapy. Additionally, the SCG received brief written healthy lifestyle advice, while intervention arms participated in an intensive 6-month behavioral intervention that consisted of seven 60-min group counselling sessions. Both intervention arms received counselling aiming at a 5-10% weight loss and an increase in the level of adherence to the MD. The MLG also received counselling on increasing physical activity and achieving adequate sleep duration and quality. Anthropometric indices, lifestyle habits, polysomnographic data, OSA symptoms, biochemical indices, blood pressure, the presence of the metabolic syndrome (MS), as well as inflammatory and oxidative stress markers, were evaluated both pre- and post-intervention. Results: A total of 187 patients were recruited and randomized (65-SCG, 62-MDG and 60-MLG). Seven patients were excluded post-randomization and 53/180 (29%) were lost to follow-up. According to intention to treat analysis (n=180), compared to the SCG, post-intervention age-, sex-, baseline- and CPAP use-adjusted AHI levels (events/h) were significantly lower in the MDG (mean difference: -18.0, P<0.001) and the MLG (mean difference: -21.2, P<0.001), and the differences remained significant after further adjustment for percent body-weight change (P=0.004 and P=0.008, respectively). Other respiratory event indices and symptoms of daytime sleepiness and insomnia were also significantly lower in intervention arms compared to the SCG (all P<0.050). The MLG only presented higher percent rapid-eye-movement sleep and lower degree of daytime sleepiness compared to the MDG (P=0.034 and P=0.014, respectively). Indices of glucose metabolism, blood lipids, liver enzymes and blood pressure improved only in intervention arms, and were significantly lower compared to the SCG post-intervention (all P<0.050). The age-, sex-, baseline- and CPAP use-adjusted relative risk (95% confidence interval) of MS was 0.58 (0.34-0.99) for the MDG and 0.30 (0.17-0.52) for the MLG, compared to the SCG. The MLG additionally presented a lower relative risk of MS compared to the MDG [0.52 (0.30-0.89)]. After further adjustment for percent body-weight change, a lower relative risk of MS was still evident for the MLG compared to the SCG (P=0.050). Moreover, compared to the SCG, post-intervention age-, sex-, baseline- and CPAP use-adjusted plasma high sensitivity C-reactive protein levels (mg/L) were lower in the MDG (mean difference: -1.33, P=0.039) and the MLG (mean difference: -1.68, P=0.007). The MLG also exhibited lower levels of urinary 8-iso prostaglandin F2a (ng/mg creatinine) compared to both the SCG (mean difference: -1.10, P<0.001) and the MDG (mean difference: -0.80, P=0.001), and the differences remained significant after further adjustment for percent body-weight change (P<0.001 and P<0.001, respectively). Results were similar in per-protocol analysis (n=127). Conclusions: The addition of a weight-loss MD/ML intervention to OSA standard care, i.e. CPAP prescription, has an incremental effect on reducing OSA severity and symptomatology, improving cardiometabolic indices and ameliorating inflammation and oxidative stress, over standard care alone. Behavioral interventions towards a modest weight loss through beneficial changes in lifestyle habits that do not require sophisticated equipment and can be feasible in all healthcare services could constitute a realistic and efficient plan for the management of OSA in clinical practice.

Degree

thesis:*
Grantor dc:publisher
Harokopio University
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Georgoulis, Michael
  • Γεωργούλης, Μιχαήλ

Subjects

dc:subject × 22

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/49102

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Georgoulis, Michael; Γεωργούλης, Μιχαήλ. Η επίδραση του μεσογειακού τρόπου ζωής σε κλινικά και βιοχημικά χαρακτηριστικά ασθενών με αποφρακτική άπνοια ύπνου. Harokopio University, 2021. http://hdl.handle.net/10442/hedi/49102